Vimarsana
Biggest News Aggregation in the World

Page 2 - Presented August News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presented August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presented August Today - Breaking & Trending Today

Cardiac Arrest Centers No Benefit in OHCA Without STEMI - Vimarsana News

Cardiac Arrest Centers No Benefit in OHCA Without STEMI

Patients resuscitated after cardiac arrest without ST elevation had the same survival if they were transported to the nearest hospital emergency department or a cardiac arrest center, in the UK ARREST trial.

Pulsed Field Ablation Challenges Conventional Devices in AF - Vimarsana News

Pulsed Field Ablation Challenges Conventional Devices in AF

In the ADVENT trial, pulsed field ablation, a new technology for terminating drug-refractory paroxysmal AF, was noninferior to conventional thermal ablation but had potential advantages.

IV Iron Shows Only Modest Benefit in HF: HEART-FID - Vimarsana News

IV Iron Shows Only Modest Benefit in HF: HEART-FID

The largest ever study of IV iron supplementation in patients with heart failure failed to meet a new rigorous definition of significance, and the results were generally regarded as disappointing.

ESC Backs SGLT2i Plus GLP-1 in Diabetes with High CVD Risk - Vimarsana News

ESC Backs SGLT2i Plus GLP-1 in Diabetes with High CVD Risk

New ESC guidelines recommend using both an SGLT2 inhibitor and a GLP-1 receptor agonist simultaneously to treat people with type 2 diabetes and established cardiovascular disease.

995861 - Vimarsana News

995861

Among patients with atrial high-rate episodes detected by implantable devices, anticoagulation with edoxaban did not show a benefit but did increase bleeding risk in the NOAH-AFNET 6 trial.